We are studying new immunotherapy strategies for patients with advanced triple-negative breast cancer. The goal is to see if these treatments are safe and effective, and to learn more about how tumors respond to them.
Health conditions and diseases that the clinical trial is designed to study and treat.
Metastatic Triple Negative Breast Cancer (TNBC) is a type of breast cancer that has spread beyond the breast to other parts of the body. It is characterized by the absence of estrogen, progesterone, and HER2 receptors, making it more challenging to treat.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.